Lina Maria Nilsson

Title: Lina Maria Nilsson: Innovator in Machine Learning and Perturbation Data Synthesis

Introduction

Lina Maria Nilsson is a prominent inventor based in Salt Lake City, Utah. She has made significant contributions to the field of machine learning, particularly in the synthesis of perturbation data. Her innovative work has led to the development of advanced graphical user interfaces that enhance the understanding of cellular perturbations.

Latest Patents

Lina holds a patent for her invention titled "Utilizing machine learning models to synthesize perturbation data to generate perturbation heatmap graphical user interfaces." This patent describes systems, non-transitory computer-readable media, and methods for embedding perturbation data via a machine learning model. The invention focuses on filtering, aligning, and aggregating embeddings to create a genome-wide perturbation database for real-time generation of perturbation heatmaps. The systems can receive a variety of perturbation images portraying cells from multiple wells, generate well-level image embeddings, and align these embeddings to produce aligned well-level image embeddings. Furthermore, the systems can aggregate these embeddings according to perturbations from various experiments, ultimately generating perturbation comparisons.

Career Highlights

Lina is currently employed at Recursion Pharmaceuticals, Inc., where she applies her expertise in machine learning to advance the company's research initiatives. Her work is instrumental in developing innovative solutions that leverage data to improve understanding in the field of pharmaceuticals.

Collaborations

Lina collaborates with notable colleagues, including Marta Marie Fay and August Orvis Allen. Their combined efforts contribute to the advancement of research and innovation within their organization.

Conclusion

Lina Maria Nilsson is a trailblazer in the realm of machine learning and perturbation data synthesis. Her patent and work at Recursion Pharmaceuticals, Inc. exemplify her commitment to innovation and the advancement of scientific research.